Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
106M
-
Number of holders
-
183
-
Total 13F shares, excl. options
-
42.4M
-
Shares change
-
+7.87M
-
Total reported value, excl. options
-
$2.6B
-
Value change
-
+$579M
-
Put/Call ratio
-
1.29
-
Number of buys
-
116
-
Number of sells
-
-70
-
Price
-
$61.41
Significant Holders of Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT) as of Q3 2016
265 filings reported holding SRPT - Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share as of Q3 2016.
Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT) has 183 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 42.4M shares
of 106M outstanding shares and own 40.15% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (3.68M shares), PERCEPTIVE ADVISORS LLC (3.4M shares), Point72 Asset Management, L.P. (3.28M shares), STATE STREET CORP (2.96M shares), Jefferies Group LLC (2.32M shares), MILLENNIUM MANAGEMENT LLC (1.96M shares), BlackRock Fund Advisors (1.72M shares), Tourbillon Capital Partners, L.P. (1.71M shares), FMR LLC (1.53M shares), and JENNISON ASSOCIATES LLC (1.39M shares).
This table shows the top 183 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.